3.32 USD
▲+0.07+4.73%
盘后 3.17 0.00%
2026-08-03
市值
$722.77M
市盈率
—
EPS
-0.39
股息率
—
52 周区间
1.72 – 8.21
成交量
2.44M
Beta
2.08
目标价
12.50
52W 低 1.7252W 高 8.21
价格走势
公司简介
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclin...